Erschienen in:
01.03.2000 | Oral presentation
Clinical trials in breast cancer; do we have the right approaches?
verfasst von:
PE Lønning
Erschienen in:
Breast Cancer Research
|
Sonderheft 1/2000
Einloggen, um Zugang zu erhalten
Excerpt
While adjuvant chemotherapy as well as hormone therapy improve long-term survival in breast cancer patients [
1,
2], only about 25-30% of patients at risk are cured by such treatment modalities. While improved regimens using more effective chemotherapeutics have been shown to improve outcome marginally [
3], the disappointing results from high-dose chemotherapy with stem cell support [
4,
5] underlines the limitations associated with current chemotherapy. …